SCHEMBL22433124

SCHEMBL22433124

COCC(=O)N1CCC(S(=O)(=O)NC(=O)Nc2c(C(C)C)cccc2C(C)C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24922408 0.89 — —
SCHEMBL22433127 0.88 HSD17B10 (0.36) —
SCHEMBL22433125 0.88 NLRP3 (0.42) —
SCHEMBL22433122 0.87 NLRP3 (0.47) —
SCHEMBL22433082 0.85 NLRP3 (0.49) —
SCHEMBL22433086 0.84 NLRP3 (0.48) —
SCHEMBL22433442 0.83 NLRP3 (0.47) —
SCHEMBL22433439 0.82 NLRP3 (0.51) —
SCHEMBL20634278 0.82 NLRP3 (0.46) —
SCHEMBL22433573 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230037255-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LTD (IE) 2023-02-02 — — US disclosed
US-20200291003-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS SYGNATURE DISCOVERY LIMITED (GB) 2020-09-17 — — US disclosed
Send feedback